Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

DURECT Announces Top-Line Results from Psoriasis Clinical Trial

americanpharmaceuticalreviewJanuary 03, 2020

Tag: DURECT , psoriasis , DUR-928

PharmaSources Customer Service